rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1999-11-30
|
pubmed:abstractText |
TP53 gene plays a major role in the process of malignant transformation and tumour progression so that abnormalities such as point mutation or allelic loss of this gene are a common finding in different tumour types. Most of the mutations identified cover a conserved region of the gene, spanning from exon 4 to exon 9. The present report describes a novel polymorphism, 12 nucleotides downstream the splicing junction of exon/intron 9 identified in a cohort of 103 Italian healthy blood donors. The polymorphism results in the creation of a new restriction site for Ava I.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0890-8508
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 1999 Academic Press.
|
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
393-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10508562-Blood Donors,
pubmed-meshheading:10508562-DNA Restriction Enzymes,
pubmed-meshheading:10508562-Exons,
pubmed-meshheading:10508562-Female,
pubmed-meshheading:10508562-Gene Frequency,
pubmed-meshheading:10508562-Genes, p53,
pubmed-meshheading:10508562-Humans,
pubmed-meshheading:10508562-Introns,
pubmed-meshheading:10508562-Italy,
pubmed-meshheading:10508562-Male,
pubmed-meshheading:10508562-Point Mutation,
pubmed-meshheading:10508562-Polymorphism, Genetic,
pubmed-meshheading:10508562-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:10508562-Polymorphism, Single-Stranded Conformational
|
pubmed:year |
1999
|
pubmed:articleTitle |
An Ava I polymorphism in the TP53 gene.
|
pubmed:affiliation |
Il Department of Pathology, University of Milan School of Medicine, Via A di Rudinì 8, Milano, 20142, Italy.
|
pubmed:publicationType |
Journal Article
|